Skip to main content
Premium Trial:

Request an Annual Quote

Duke Gets $3M Gates Grant to Discover Genetic Roots of HIV Resistance in Hemophilia

NEW YORK (GenomeWeb News) – The Bill and Melinda Gates Foundation has given Duke University a two-year, $3 million grant to identify genetic variants responsible for making some people with hemophilia immune to HIV infection.
The Center for Human Genome Variation at Duke’s Institute for Genome Sciences and Policy will use the funding to resequence the genomes of 50 individuals with hemophilia in order to discover variants that are most likely to be associated with HIV resistance, Duke University said earlier this week.
Past research has shown that “a significant minority” of hemophilia patients who were exposed to HIV-infected blood in the 1970s and 1980s did not contract the disease, Duke said. 
Previous studies have shown that these HIV-resistant individuals are 15 times more likely to carry a deletion in the HIV main co-receptor CCR5 than the general population, said David Goldstein, the institute’s director, in a statement.
However, Goldstein noted that known genetic variants explain only a small amount of the differences among individuals exposed to the HIV virus. “We think there are probably other, much rarer variants that also play a role,” he continued. “We just haven't had the right tools to find them, but now we do.”
The Duke researchers will resequence the genomes of 50 individuals who were treated with contaminated factor VIII concentrate between 1979 and 1984 but did not contract HIV.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.